NCT03755908

Brief Summary

Exhibiting variable airway obstruction is a key factor in the diagnosis of asthma but too often it is undetected by spirometry. Study hypothesis: The forced oscillation technique (FOT) will show airway obstruction in asthmatic children with normal spirometry pointing out its advantage in measuring AW obstruction in this population. We will conduct a prospective observational study in 6-18 years old children with the diagnosis of asthma and a normal spirometry results. Each subject will undergo evaluation including: asthma control questionnaire, spirometry, FOT and Fractional exhaled nitric oxide (FeNO) to assess the sensitivity of FOT in diagnosing airway obstruction in this circumstances.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 28, 2018

Completed
3 days until next milestone

Study Start

First participant enrolled

December 1, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

November 28, 2018

Status Verified

November 1, 2018

Enrollment Period

1.8 years

First QC Date

October 16, 2018

Last Update Submit

November 25, 2018

Conditions

Keywords

Forced oscillation techniqueAirway obstructionAsthma

Outcome Measures

Primary Outcomes (4)

  • R5

    Resistances at the frequency of 5 hertz in kilopascal per liter per second

    One year

  • R20

    Resistances at the frequency of 20 hertz in kilopascal per liter per second

    One year

  • R5-R20

    The difference between R5 to R20 in kilopascal per liter per second

    One year

  • Xrs 5

    Reactance at the frequency of 5 hertz in kilopascal per liter

    One year

Secondary Outcomes (1)

  • FeNO

    One year

Study Arms (1)

asthmatic children

Children with the diagnosis of asthma and normal spirometry results. Each subject will undergo evaluation including: asthma control questionnaire, spirometry, FOT and Fractional exhaled nitric oxide (FeNO).

Device: Forced oscillation technique (FOT)

Interventions

FOT will be measured using the TremoFlo C-100 Airwave Oscillometry System (Thorasys , Montreal, Quebec, Canada). R5, R20, R5-20 (resistances in the reported frequency), X5 (reactance in 5hz) and Ax5 (reactance area in 5hz) will be reported.

asthmatic children

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Children with the diagnosis of asthma and a normal spirometry results

You may qualify if:

  • Diagnosis of asthma
  • Must be able to perform spirometry and FOT tests
  • Normal spirometry results (FEV1 \& FEV1/FVC \>80% and FEF25-75\>65%)

You may not qualify if:

  • Chronic lung disease other than asthma
  • Severe chronic medical condition such as heart failure, neuromuscular disease etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rambam Medical Center

Haifa, 32000, Israel

Location

MeSH Terms

Conditions

Airway ObstructionAsthma

Condition Hierarchy (Ancestors)

Respiratory InsufficiencyRespiration DisordersRespiratory Tract DiseasesBronchial DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Lea Bentur, MD

    Rambam Medical Center, Haifa, Israel

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2018

First Posted

November 28, 2018

Study Start

December 1, 2018

Primary Completion

October 1, 2020

Study Completion

October 1, 2021

Last Updated

November 28, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

Locations